VERONA PHARMA
LIVE

Serial Number

99060189

Owner

VERONA PHARMA LIMITED

Attorney

John M. Mueller

Filing Date

Feb 27, 2025

Add to watchlist:

No watchlists yet
View on USPTO

VERONA PHARMA Trademark

Serial Number: 99060189 • Registration: 8001981

VERONA PHARMA is a trademark filed by VERONA PHARMA LIMITED on February 27, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

VERONA PHARMA LIMITED

120 MOORGATE
LONDON EC2M 6UR , GB

Entity Type: 99

Verona Pharma PLC

One Central Square
Cardiff CF101FS , GB

Entity Type: 84

Trademark Details

Filing Date

February 27, 2025

Registration Date

October 28, 2025

Published for Opposition

September 9, 2025

Goods & Services

Pharmaceutical preparations and substances for the treatment of cardiovascular, central nervous system, pulmonary, respiratory, autoimmune diseases and disorders for human use; Pharmaceutical preparations and substances for the treatment of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma

Medical treatment services for the treatment of cardiovascular, central nervous system, pulmonary, respiratory, autoimmune diseases and disorders; Provision of medical information and services; Information provided to patients and healthcare professionals concerning pharmaceutical products, vaccines, medical diseases and disorders and related treatments; Medical treatment services in the field of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma; Provision of medical information and services in the field of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma

Scientific research for medical purposes in the field of the treatment of cardiovascular, central nervous system, pulmonary, respiratory, autoimmune diseases and disorders; Scientific research for medical purposes, namely, the research and development of pharmaceutical preparations for the treatment of respiratory conditions and disease, in particular, chronic obstructive pulmonary disease, cystic fibrosis and asthma

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 20, 2026 ASGN
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 28, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 28, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 9, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 9, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 3, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 11, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 7, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 7, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 7, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 2, 2025 GNRN
NON-FINAL ACTION E-MAILED
Aug 2, 2025 GNRT
NON-FINAL ACTION WRITTEN
Aug 2, 2025 CNRT
ASSIGNED TO EXAMINER
Aug 1, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 22, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 22, 2025 NWOS
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Mar 4, 2025 TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Mar 4, 2025 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Mar 4, 2025 PARI
APPLICATION FILING RECEIPT MAILED
Feb 27, 2025 MAFR
NEW APPLICATION ENTERED
Feb 27, 2025 NWAP